Tumor Biology

, Volume 35, Issue 3, pp 2491–2496 | Cite as

An updated meta-analysis of the association between ADIPOQ rs2241766 polymorphism and colorectal cancer

  • Peng Li
  • Hongyi Liu
  • Chen Li
  • Bo Yang
  • Qinglong Kong
  • Wei Zheng
  • Bing Li
  • Baoqing Jia
Research Article


Adiponectin (ADIPOQ) is a cytokine produced by adipose tissue involved in carcinogenesis. ADIPOQ SNP rs2241766 has been extensively studied in colorectal cancer (CRC) community with contentious and conflicting conclusions. The objective of this study was to comprehensively assess the association between SNP rs2241766 and CRC risk. PubMed, Embase, CNKI, as well as the references of the retrieved articles were searched to identify the eligible studies for this meta-analysis. Odds ratios (ORs) and 95 % confidence intervals (CIs) were used to assess the association. We also examined the heterogeneity and publication bias and performed sensitivity analyses. Seven studies with 2,414 cases and 2,796 controls together did not show any significant association between SNP rs2241766 and CRC risk. Subgroup analyses by ethnicity and sample size also failed to provide statistically significant evidence. This meta-analysis demonstrates that ADIPOQ SNP rs2241766 may not represent as an effect modifier for the risk of CRC.


ADIPOQ CRC Meta-analysis 


  1. 1.
    Peto J. Cancer epidemiology in the last century and the next decade. Nature. 2001;411(6835):390–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Parkin DM et al. Global cancer statistics. CA Cancer J Clin. 2005;55(2):74–108.PubMedCrossRefGoogle Scholar
  3. 3.
    Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science. 1997;278(5340):1043–50.PubMedCrossRefGoogle Scholar
  4. 4.
    Risch N. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev. 2001;10(7):733–41.PubMedGoogle Scholar
  5. 5.
    Lichtenstein P et al. Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78–85.PubMedCrossRefGoogle Scholar
  6. 6.
    Pischon T et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98(13):920–31.PubMedCrossRefGoogle Scholar
  7. 7.
    Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr. 2007;86(3):556–65.PubMedGoogle Scholar
  8. 8.
    Housa D et al. Adipocytokines and cancer. Physiol Res. 2006;55(3):233–44.PubMedGoogle Scholar
  9. 9.
    Huang XF, Chen JZ. Obesity, the PI3K/Akt signal pathway and colon cancer. Obes Rev. 2009;10(6):610–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Drew JE et al. Insulin, leptin, and adiponectin receptors in colon: regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine. Am J Physiol Gastrointest Liver Physiol. 2007;293(4):G682–91.PubMedCrossRefGoogle Scholar
  11. 11.
    Williams CJ et al. Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocr Relat Cancer. 2008;15(1):289–99.PubMedCrossRefGoogle Scholar
  12. 12.
    Wei EK et al. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst. 2005;97(22):1688–94.PubMedCrossRefGoogle Scholar
  13. 13.
    Sherry ST et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308–11.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Menzaghi C et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes. 2002;51(7):2306–12.PubMedCrossRefGoogle Scholar
  15. 15.
    Yang WS et al. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med (Berl). 2003;81(7):428–34.CrossRefGoogle Scholar
  16. 16.
    Kaklamani VG et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA. 2008;300(13):1523–31.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Partida-Perez M et al. Association of LEP and ADIPOQ common variants with colorectal cancer in Mexican patients. Cancer Biomark. 2010;7(3):117–21.PubMedGoogle Scholar
  18. 18.
    He B et al. Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population. BMC Med Genet. 2011;12:94.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Zhang Y, Feng QL, Liu CM, et al. Relationship between polymorphism sites of adiponection and it’s receptor gene and the susceptibility of colorectal cancer. Jiangsu Daxue Xuebao (Medical Edition). 2012;22:336–41.Google Scholar
  20. 20.
    Liu, L., Adiponectin and leptin gene families with colorectal cancer-study on susceptibility and progression of disease. Dissertation. Huazhong University of Science and Technology, 2012Google Scholar
  21. 21.
    Al-Harithy RN, Al-Zahrani MH. The adiponectin gene, ADIPOQ, and genetic susceptibility to colon cancer. Oncol Lett. 2012;3(1):176–80.PubMedCentralPubMedGoogle Scholar
  22. 22.
    Hu X et al. Gene Polymorphisms of +45T>G, −866G>A, and ala54thr on the risk of colorectal cancer: a matched case–control study. PLoS One. 2013;8(6):e67275.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Xu Y et al. The roles of ADIPOQ genetic variations in cancer risk: evidence from published studies. Mol Biol Rep. 2013;40(2):1135–44.PubMedCrossRefGoogle Scholar
  24. 24.
    Ye C et al. Meta-analysis of adiponectin polymorphisms and colorectal cancer risk. Int J Med Sci. 2013;10(9):1113–20.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Zhou W, Liu Y, Zhong DW. Adiponectin (ADIPOQ) rs2241766 G/T polymorphism is associated with risk of cancer: evidence from a meta-analysis. Tumour Biol. 2013;34(1):493–504.PubMedCrossRefGoogle Scholar
  26. 26.
    Cochran W. The combination of estimates from different experiments. Biometrics. 1954;10(1):101–29.CrossRefGoogle Scholar
  27. 27.
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.PubMedCrossRefGoogle Scholar
  28. 28.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.PubMedGoogle Scholar
  29. 29.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.PubMedCrossRefGoogle Scholar
  30. 30.
    Egger M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Beebe-Dimmer JL et al. Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans. Prostate Cancer Prostatic Dis. 2010;13(4):362–8.PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Teras LR et al. No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18(9):2553–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Pechlivanis S et al. Genetic variation in adipokine genes and risk of colorectal cancer. Eur J Endocrinol. 2009;160(6):933–40.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  • Peng Li
    • 1
  • Hongyi Liu
    • 1
  • Chen Li
    • 2
  • Bo Yang
    • 3
  • Qinglong Kong
    • 1
  • Wei Zheng
    • 1
  • Bing Li
    • 1
  • Baoqing Jia
    • 1
  1. 1.Department of Oncology SurgeryChinese PLA General HospitalBeijingChina
  2. 2.Department of EmergencyChinese PLA General HospitalBeijingChina
  3. 3.Department of General Thoracic SurgeryChinese PLA General HospitalBeijingChina

Personalised recommendations